IRIS
TOMASSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.997
AS - Asia 2.649
EU - Europa 1.535
SA - Sud America 459
Continente sconosciuto - Info sul continente non disponibili 425
AF - Africa 62
OC - Oceania 15
Totale 10.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.867
SG - Singapore 1.467
CN - Cina 476
IT - Italia 366
BR - Brasile 361
RU - Federazione Russa 355
VN - Vietnam 293
IE - Irlanda 279
GB - Regno Unito 112
DE - Germania 102
HK - Hong Kong 98
SE - Svezia 85
IN - India 73
BD - Bangladesh 60
CA - Canada 59
FI - Finlandia 37
AR - Argentina 36
JP - Giappone 33
MX - Messico 31
ES - Italia 27
AT - Austria 24
FR - Francia 24
PL - Polonia 22
KR - Corea 21
TR - Turchia 21
UA - Ucraina 21
IQ - Iraq 20
ZA - Sudafrica 20
EC - Ecuador 14
NL - Olanda 14
AU - Australia 13
JM - Giamaica 13
PK - Pakistan 13
VE - Venezuela 13
ID - Indonesia 10
BE - Belgio 9
CH - Svizzera 9
CZ - Repubblica Ceca 9
IR - Iran 9
LT - Lituania 9
PY - Paraguay 9
CL - Cile 8
CO - Colombia 8
KE - Kenya 8
MA - Marocco 8
RO - Romania 7
UZ - Uzbekistan 7
EG - Egitto 6
HN - Honduras 6
SA - Arabia Saudita 6
CR - Costa Rica 5
PA - Panama 5
PE - Perù 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DZ - Algeria 4
JO - Giordania 4
KZ - Kazakistan 4
IL - Israele 3
MY - Malesia 3
OM - Oman 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
CY - Cipro 2
EU - Europa 2
GA - Gabon 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
MQ - Martinica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
KH - Cambogia 1
LB - Libano 1
MC - Monaco 1
Totale 9.707
Salva come PNG Salva come JPEG
Città #
Singapore 1.154
Dallas 945
San Jose 657
Ashburn 375
Chandler 286
Dublin 275
Council Bluffs 219
Santa Clara 185
Beijing 153
Los Angeles 116
The Dalles 100
Hong Kong 94
Ho Chi Minh City 86
Jacksonville 84
Princeton 82
New York 60
Hanoi 57
St Louis 57
Columbus 51
Hefei 51
Tongling 48
Buffalo 47
Munich 44
Orem 44
Phoenix 43
Altamura 41
São Paulo 39
Moscow 34
Rome 34
Dong Ket 33
Tokyo 32
Redondo Beach 31
Wilmington 30
Nuremberg 29
Chicago 27
London 25
Washington 24
Chennai 23
Brooklyn 22
Denver 22
Pescara 22
Montreal 21
Seoul 21
Atlanta 20
Milan 20
Seattle 20
Chieti 18
Houston 18
Warsaw 18
Boston 17
Haiphong 17
Mexico City 16
Ann Arbor 15
Da Nang 15
Helsinki 15
Mumbai 14
Romola 14
Stockholm 14
Teramo 14
Johannesburg 13
Lappeenranta 13
Falls Church 12
Boardman 11
Frankfurt am Main 11
San Francisco 11
Camerino 10
Naples 10
Brussels 9
Campinas 9
Manchester 9
New Delhi 9
Rio de Janeiro 9
Toronto 9
Baghdad 8
Fairfield 8
Memphis 8
Southend 8
Tehran 8
Vienna 8
Biên Hòa 7
Brasília 7
Castignano 7
Istanbul 7
Kingston 7
Poplar 7
Saint Petersburg 7
Sydney 7
Tashkent 7
Turku 7
Woodbridge 7
Cairo 6
Cardiff 6
Dhaka 6
Düsseldorf 6
Florence 6
Nairobi 6
Nanchang 6
Norwalk 6
Padua 6
Porto Alegre 6
Totale 6.418
Salva come PNG Salva come JPEG
Nome #
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 193
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 171
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 168
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 164
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 158
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 152
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 146
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 145
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 145
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 143
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 138
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 138
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 136
Brain morphometry in Multiple Sclerosis 134
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 134
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 131
Modelling the natural history of primary progressive multiple sclerosis 129
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 126
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 124
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 124
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 123
Tractography in the presence of multiple sclerosis lesions 123
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 119
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 116
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 115
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 115
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 114
Neuroplasticity and motor rehabilitation in multiple sclerosis 114
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 113
Neurological update: MOG antibody disease 112
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 112
Age-related changes in grey and white matter structure throughout adulthood 111
Lessons from immunotherapies in multiple sclerosis 106
Oral contraceptives combined with interferon b in multiple sclerosis 105
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression 103
How common is truly benign MS in a UK population? 102
Medical education and MS: getting the training right 99
Predicting the profile of increasing disability in multiple sclerosis 99
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 99
Informing MS patients on treatment options: a consensus on the process of consent taking 97
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 97
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 97
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 95
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 95
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 93
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 93
Investigating social cognition in Multiple Sclerosis: Does Implicit Biological Motion processing affect visuo-spatial attention? 92
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 91
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 91
Site-specific clinical disease onset in multiple sclerosis 90
Alexithymia in multiple sclerosis: relationship with fatigue and depression 89
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 89
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 89
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 88
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 88
Model-free characterization of brain functional networks for motor sequence learning using fMRI 88
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 87
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 86
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 85
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 85
Similarities and differences between multiple sclerosis and type 1 diabetes 85
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 85
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 84
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 83
Exploring the contribution of gray matter microstructure to R1 contrast via multi-compartment diffusion modelling in the healthy brain 83
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 83
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 82
Neuroplasticity and functional recovery in multiple sclerosis 82
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 81
Relating brain damage to brain plasticity in patients with multiple sclerosis 81
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 81
Changes in brain perfusion with training-related visuomotor improvement in MS 81
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 80
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 79
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 78
Diagnosis and management of multiple sclerosis: MRI in clinical practice 78
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 76
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 75
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 74
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 73
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 72
Structural and functional bases for individual differences in motor learning 72
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 72
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 72
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 69
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 68
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 67
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 67
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 67
Preservation of motor skill learning in patients with multiple sclerosis 66
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 64
Sex hormones, brain damage and clinical course of Multiple Sclerosis 63
Multiple sclerosis lesions: insights from imaging techniques 63
Contemporary study of multiple sclerosis disability in South East Wales 63
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 61
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 60
Sex hormones: a role in the control of multiple sclerosis? 57
Transverse myelitis in children and adults 55
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 52
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 49
Totale 9.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022207 0 0 3 3 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20252.205 120 544 421 52 47 58 76 82 192 147 161 305
2025/20265.074 334 224 1.141 528 345 187 596 320 529 438 295 137
2026/2027687 189 333 165 0 0 0 0 0 0 0 0 0
Totale 10.142